[1]
Panayiotopoulos CP, Obeid T, Tahan AR. Juvenile myoclonic epilepsy: a 5-year prospective study. Epilepsia. 1994 Mar-Apr:35(2):285-96
[PubMed PMID: 8156946]
[2]
Hauser WA. The prevalence and incidence of convulsive disorders in children. Epilepsia. 1994:35 Suppl 2():S1-6
[PubMed PMID: 8275976]
[3]
Janz D. Epilepsy with impulsive petit mal (juvenile myoclonic epilepsy). Acta neurologica Scandinavica. 1985 Nov:72(5):449-59
[PubMed PMID: 3936330]
[4]
Canevini MP,Mai R,Di Marco C,Bertin C,Minotti L,Pontrelli V,Saltarelli A,Canger R, Juvenile myoclonic epilepsy of Janz: clinical observations in 60 patients. Seizure. 1992 Dec
[PubMed PMID: 1344779]
[5]
Buraei Z, Yang J. The ß subunit of voltage-gated Ca2+ channels. Physiological reviews. 2010 Oct:90(4):1461-506. doi: 10.1152/physrev.00057.2009. Epub
[PubMed PMID: 20959621]
[6]
Delgado-Escueta AV, Koeleman BP, Bailey JN, Medina MT, Durón RM. The quest for juvenile myoclonic epilepsy genes. Epilepsy & behavior : E&B. 2013 Jul:28 Suppl 1():S52-7. doi: 10.1016/j.yebeh.2012.06.033. Epub
[PubMed PMID: 23756480]
[7]
Liu M, Concha L, Beaulieu C, Gross DW. Distinct white matter abnormalities in different idiopathic generalized epilepsy syndromes. Epilepsia. 2011 Dec:52(12):2267-75. doi: 10.1111/j.1528-1167.2011.03313.x. Epub 2011 Nov 16
[PubMed PMID: 22092238]
[8]
Tae WS, Kim SH, Joo EY, Han SJ, Kim IY, Kim SI, Lee JM, Hong SB. Cortical thickness abnormality in juvenile myoclonic epilepsy. Journal of neurology. 2008 Apr:255(4):561-6. doi: 10.1007/s00415-008-0745-6. Epub 2008 Jan 31
[PubMed PMID: 18227991]
[9]
Mory SB, Betting LE, Fernandes PT, Lopes-Cendes I, Guerreiro MM, Guerreiro CA, Cendes F, Li LM. Structural abnormalities of the thalamus in juvenile myoclonic epilepsy. Epilepsy & behavior : E&B. 2011 Aug:21(4):407-11. doi: 10.1016/j.yebeh.2011.05.018. Epub 2011 Jun 23
[PubMed PMID: 21700499]
[10]
Vijai J, Cherian PJ, Stlaja PN, Anand A, Radhakrishnan K. Clinical characteristics of a South Indian cohort of juvenile myoclonic epilepsy probands. Seizure. 2003 Oct:12(7):490-6
[PubMed PMID: 12967578]
[11]
Jayalakshmi SS, Srinivasa Rao B, Sailaja S. Focal clinical and electroencephalographic features in patients with juvenile myoclonic epilepsy. Acta neurologica Scandinavica. 2010 Aug:122(2):115-23. doi: 10.1111/j.1600-0404.2009.01270.x. Epub 2009 Oct 19
[PubMed PMID: 19845556]
[12]
Murthy JM, Rao CM, Meena AK. Clinical observations of juvenile myoclonic epilepsy in 131 patients: a study in South India. Seizure. 1998 Feb:7(1):43-7
[PubMed PMID: 9548225]
[13]
Trinka E, Kienpointner G, Unterberger I, Luef G, Bauer G, Doering LB, Doering S. Psychiatric comorbidity in juvenile myoclonic epilepsy. Epilepsia. 2006 Dec:47(12):2086-91
[PubMed PMID: 17201708]
[14]
Moschetta S, Fiore LA, Fuentes D, Gois J, Valente KD. Personality traits in patients with juvenile myoclonic epilepsy. Epilepsy & behavior : E&B. 2011 Aug:21(4):473-7. doi: 10.1016/j.yebeh.2011.03.036. Epub 2011 Jun 17
[PubMed PMID: 21683658]
[15]
Somayajula S, Vooturi S, Jayalakshmi S. Psychiatric disorders among 165 patients with juvenile myoclonic epilepsy in India and association with clinical and sociodemographic variables. Epilepsy & behavior : E&B. 2015 Dec:53():37-42. doi: 10.1016/j.yebeh.2015.09.024. Epub 2015 Oct 28
[PubMed PMID: 26519664]
[16]
Baise-Zung C, Guilhoto LM, Grossmann RM. Juvenile myoclonic epilepsy: non-classic electroencephalographical presentation in adult patients. European journal of neurology. 2006 Feb:13(2):171-5
[PubMed PMID: 16490048]
[17]
Dhanuka AK, Jain BK, Daljit S, Maheshwari D. Juvenile myoclonic epilepsy: a clinical and sleep EEG study. Seizure. 2001 Jul:10(5):374-8
[PubMed PMID: 11488650]
[18]
Létourneau K, Cieuta-Walti C, Deacon C. Epileptiform asymetries and treatment response in juvenile myoclonic epilepsy. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques. 2010 Nov:37(6):826-30
[PubMed PMID: 21059546]
[19]
Hrachovy RA, Frost JD Jr. The EEG in selected generalized seizures. Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society. 2006 Aug:23(4):312-32
[PubMed PMID: 16885706]
[20]
Anderson J, Hamandi K. Understanding juvenile myoclonic epilepsy: contributions from neuroimaging. Epilepsy research. 2011 May:94(3):127-37. doi: 10.1016/j.eplepsyres.2011.03.008. Epub 2011 Apr 8
[PubMed PMID: 21482074]
Level 3 (low-level) evidence
[21]
Chowdhury A, Brodie MJ. Pharmacological outcomes in juvenile myoclonic epilepsy: Support for sodium valproate. Epilepsy research. 2016 Jan:119():62-6. doi: 10.1016/j.eplepsyres.2015.11.012. Epub 2015 Dec 1
[PubMed PMID: 26675554]
[22]
Tomson T, Battino D, Perucca E. Valproic acid after five decades of use in epilepsy: time to reconsider the indications of a time-honoured drug. The Lancet. Neurology. 2016 Feb:15(2):210-218. doi: 10.1016/S1474-4422(15)00314-2. Epub 2015 Dec 5
[PubMed PMID: 26655849]
[23]
Bodenstein-Sachar H, Gandelman-Marton R, Ben-Zeev B, Chapman J, Blatt I. Outcome of lamotrigine treatment in juvenile myoclonic epilepsy. Acta neurologica Scandinavica. 2011 Jul:124(1):22-7. doi: 10.1111/j.1600-0404.2010.01472.x. Epub 2011 Jan 6
[PubMed PMID: 21208196]
[24]
Verrotti A, Cerminara C, Coppola G, Franzoni E, Parisi P, Iannetti P, Aloisi P, Tozzi E, Cusmai R, Vigevano F, Chiarelli F, Curatolo P. Levetiracetam in juvenile myoclonic epilepsy: long-term efficacy in newly diagnosed adolescents. Developmental medicine and child neurology. 2008 Jan:50(1):29-32. doi: 10.1111/j.1469-8749.2007.02009.x. Epub
[PubMed PMID: 18173626]
[25]
Levisohn PM, Holland KD. Topiramate or valproate in patients with juvenile myoclonic epilepsy: a randomized open-label comparison. Epilepsy & behavior : E&B. 2007 Jun:10(4):547-52
[PubMed PMID: 17482520]
Level 1 (high-level) evidence
[26]
Liu J, Wang LN, Wang YP. Topiramate monotherapy for juvenile myoclonic epilepsy. The Cochrane database of systematic reviews. 2015 Dec 23:(12):CD010008. doi: 10.1002/14651858.CD010008.pub2. Epub 2015 Dec 23
[PubMed PMID: 26695884]
Level 1 (high-level) evidence
[27]
Kothare SV, Valencia I, Khurana DS, Hardison H, Melvin JJ, Legido A. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy. Epileptic disorders : international epilepsy journal with videotape. 2004 Dec:6(4):267-70
[PubMed PMID: 15634623]
[28]
Biraben A, Allain H, Scarabin JM, Schück S, Edan G. Exacerbation of juvenile myoclonic epilepsy with lamotrigine. Neurology. 2000 Dec 12:55(11):1758
[PubMed PMID: 11113246]
[29]
Knott C, Panayiotopoulos CP. Carbamazepine in the treatment of generalised tonic clonic seizures in juvenile myoclonic epilepsy. Journal of neurology, neurosurgery, and psychiatry. 1994 Apr:57(4):503
[PubMed PMID: 8164005]
[30]
Mantoan L, Walker M. Treatment options in juvenile myoclonic epilepsy. Current treatment options in neurology. 2011 Aug:13(4):355-70. doi: 10.1007/s11940-011-0131-z. Epub
[PubMed PMID: 21494841]
[31]
Kostov H, Larsson PG, Røste GK. Is vagus nerve stimulation a treatment option for patients with drug-resistant idiopathic generalized epilepsy? Acta neurologica Scandinavica. Supplementum. 2007:187():55-8
[PubMed PMID: 17419830]
[32]
Baykan B, Altindag EA, Bebek N, Ozturk AY, Aslantas B, Gurses C, Baral-Kulaksizoglu I, Gokyigit A. Myoclonic seizures subside in the fourth decade in juvenile myoclonic epilepsy. Neurology. 2008 May 27:70(22 Pt 2):2123-9. doi: 10.1212/01.wnl.0000313148.34629.1d. Epub
[PubMed PMID: 18505992]
[33]
Martínez-Juárez IE, Alonso ME, Medina MT, Durón RM, Bailey JN, López-Ruiz M, Ramos-Ramírez R, León L, Pineda G, Castroviejo IP, Silva R, Mija L, Perez-Gosiengfiao K, Machado-Salas J, Delgado-Escueta AV. Juvenile myoclonic epilepsy subsyndromes: family studies and long-term follow-up. Brain : a journal of neurology. 2006 May:129(Pt 5):1269-80
[PubMed PMID: 16520331]